Immuron Ltd

  • IPO date:
  • Sector: Healthcare
  • GIC Group: Pharmaceuticals, Biotechnology & Life Sciences
  • Industry: Biotechnology
  • Company website

Company description

Immuron Limited, a biopharmaceutical company, engages in the research, development, and commercialization of polyclonal antibodies in Australia, Israel, Canada, the United States, and internationally. The company operates through two segments, Research and Development, and Hyperimmune Products. It offers Travelan, an over-the-counter medicine to reduce the risk of travelers' diarrhea and risk of minor gastrointestinal disorders, as well as a dietary supplement for support digestive health and gastrointestinal tract protection; and Protectyn, an immune supplement to help maintain a healthy digestive function and liver. The company is also developing Travelan (IMM-124E) to reduce the risk of contracting travelers' diarrhea in the United States, and Travelers' Diarrhea; and IMM-529, for treating patients suffering from recurring clostridium difficile infection. It has a research agreement with Naval Medical Research Center to develop and clinically evaluate a therapeutic targeting Campylobacter and enterotoxigenic Escherichia coli infections; and a collaboration agreement with the Walter Reed Army Institute of Research to develop an oral therapeutic for shigellosis. Immuron Limited was incorporated in 1994 and is headquartered in Carlton, Australia.

Financial highlights

Market Capitalization$18.2239 million
P/E Ratio0
P/E Growth Ratio0
Book Value0.086
Dividend Per Share0
Earnings Per Share-0.02
EBITDA-3,401.562
Profit Margin-2.0981
Operating Margin TTM-1.8889
Return on Assets TTM-0.091
Return on Equity TTM-0.177
Revenue TTM1,804.705

Income statement highlights

All numbers are in thousands

Date Total Revenue Cost of Revenue Gross Profit Total Operating Expenses
2000-06-30 55
2001-06-30 488.232 814.116 -325.884 1,591.779
2002-06-30 1,981.753 1,363 618.753 2,523.306
2003-06-30 3,429 2,019
2004-06-30 3,677.553 2,354.881 1,322.672 3,422.345
2005-06-30 4,867.597 7,069.882 -2,202.285 352.978
2006-06-30 4,002.371 2,577.171 1,425.2 5,796.181
2007-06-30 4,249.324 3,830.426 418.898 5,020.129
2008-06-30 292.904 271.032 21.872 4,014.058
2009-06-30 524.102 172.936 351.166 3,321.659
2010-06-30 461.89 275.43 186.46 2,450.939
2011-06-30 213.951 216.641 -2.69 2,886.593
2012-06-30 449.012 363.717 85.295 3,388.265
2013-06-30 149.755 193.257 -43.502 3,197.716
2014-06-30 1,044.142 332.686 711.456 3,422.366
2015-06-30 1,002.38 509.301 493.079 3,198.984
2016-06-30 1,001.077 570.183 430.894 6,948.146
2017-06-30 1,396.197 880.674 515.523 6,928.101
2018-06-30 1,842.909 870.392 972.517 4,060.994
2019-06-30 2,387.426 667.371 1,720.055 6,340.821
2020-06-30 2,518.566 688.836 1,829.73 4,746.64
2021-06-30 145.776 51.071 94.705 7,288.448
2022-06-30 765.193 241.691 523.502 3,640.915
2023-06-30 1,804.705 495.558 1,309.147 4,715.667

Balance sheet highlights

All numbers are in thousands

Date Cash Total Assets Total Liabilities Short Term Debt Long Term Debt Common Stock
1999-06-30
2000-06-30 356 4,503 61 7,458
2001-06-30 306.98 7,831.401 356 4,536.094 12,045.11
2002-06-30 576.142 6,576.789 254 2,800 12,592.048
2003-06-30 382 5,955 911 27 12,592
2004-06-30 311.834 4,909.765 878 26.974 12,742.048
2005-06-30 178.66 8,054.905 1,114 3,479.217 16,984.561
2006-06-30 1,434.265 6,625.251 1,447 1,100 18,729.796
2007-06-30 672.643 3,295.978 1,376 18,750.743
2008-06-30 1,090.824 1,899.952 813 20,583.347
2009-06-30 149.67 493.029 677.9 21,458.898
2010-06-30 1,882.224 3,798.394 435.103 26,964.091
2011-06-30 750.814 2,660.215 927.836 27,721.517
2012-06-30 1,443.928 3,638.286 1,588.305 560 30,024.787
2013-06-30 1,446.712 2,526.632 2,381.646 1,146 31,357.697
2014-06-30 6,141.789 7,632.245 845.3 40,325.295
2015-06-30 3,116.074 4,548.649 1,207.81 40,335.347
2016-06-30 2,290.639 8,827.484 3,886.921 1,900.514 45,633.354
2017-06-30 3,994.924 8,286.491 1,711.565 365.864 53,632.995
2018-06-30 4,727.43 9,242.688 803.338 0 58,372.043
2019-06-30 5,119.887 8,561.647 1,210.511 0 60,511.326
2020-06-30 3,250.468 6,202.163 558.25 42.176 62,426.991
2021-06-30 25,047.281 27,053.106 1,158.049 20.498 88,361.303
2022-06-30 22,110.278 24,855.824 1,678.423 34.376 88,436.263
2023-06-30 17,159.764 21,988.182 2,371.346 289.408 88,436.263

Cash flow highlights

All numbers are in thousands

Date Net Income Total Cash Change in Cash Begin period cash End period cash Dividends
2000-06-30 356.153
2001-06-30 -1,553.517 -1,659.39 -49.173 356.153 306.98
2002-06-30 -1,699.112 -1,919.753 269.162 306.98 576.142
2003-06-30 576.142 381.82
2004-06-30 -1,162.035 -1,235.562 -69.986 381.82 311.834
2005-06-30 -1,333.389 -1,755.799 -133.174 311.834 178.66
2006-06-30 -3,559.931 -2,806.526 1,255.605 178.66 1,434.265
2007-06-30 -3,281.236 -2,994.655 -761.622 1,434.265 672.643
2008-06-30 -2,858.337 -2,074.47 418.181 672.643 1,090.824
2009-06-30 -2,317.814 -2,072.148 -941.154 1,090.824 149.67
2010-06-30 -1,905.807 -2,259.887 1,732.554 149.67 1,882.224
2011-06-30 -2,595.179 -1,969.436 -1,131.41 1,882.224 750.814
2012-06-30 -2,297.52 -2,462.659 693.114 750.814 1,443.928
2013-06-30 -3,539.117 -2,045.407 2.784 1,443.928 1,446.712
2014-06-30 -2,544.55 -2,650.577 4,695.077 1,446.712 6,141.789
2015-06-30 -2,691.82 -3,020.933 -3,025.715 6,141.789 3,116.074
2016-06-30 -7,068.767 -5,158.336 -825.435 3,116.074 2,290.639 0
2017-06-30 -6,804.154 -7,031.088 1,704.285 2,290.639 3,994.924
2018-06-30 -3,010.929 -3,527.444 732.506 3,994.924 4,727.43
2019-06-30 -4,632.743 -1,798.579 392.457 4,727.43 5,119.887 0
2020-06-30 -2,871.815 -3,147.328 -1,869.419 5,119.887 3,250.468 0
2021-06-30 -9,570.63 -4,078.747 21,796.813 3,250.468 25,047.281 0
2022-06-30 -2,591.095 -2,548.489 -2,937.003 25,047.281 22,110.278 0
2023-06-30 -3,786.507 -2,595.195 -4,950.514 22,110.278 17,159.764 0